ENL
ENLITIC CDI FORUS [ENL]
Healthcare · ASX Small Cap
$0.0070 +0.0%
Updated 26 Mar 2026 · Scores refresh every scan
Score Breakdown
Technical73
Catalyst50
Sentiment50
Fundamental51
Momentum36
Risk Gate24
Get alerts when ENL's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- RSI drifting toward oversold territory — worth watching
- MACD momentum is picking up steam
- Volume surging at 5.2x normal while price falls — heavy selling pressure
- On a tear — up 16.7% over the last 5 days
- Beating the Small Ords index — relative strength of 1.12, so it's outpacing the pack
- Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
- Volatility is contracting — like a spring being compressed, breakouts often follow
- Critical cash runway (0.9 quarters)
- Low P/S ratio (1.5x)
- Strong revenue growth (+118%)
- Near 52-week low (1% of range)
- Micro-cap ($5-20M) - high risk
- Sentiment is mixed — no strong consensus either way
- This one has been in freefall — down 77% over the past year
- Revenue growing at +118% — the top line is moving in the right direction
- Altman Z-Score distress zone (-0.93 < 1.81, low-confidence approx)
- Penny stock risk ($0.007)
- Beneish M-Score -1.07 > -1.78: likely earnings manipulation
- RBA hiking (-3pts)
Risk Signals
- Below the 200-day average — the long-term trend is still working against it
- Not enough chatter to gauge sentiment — defaulting to neutral
- The bigger volume days are the down days — volume-weighted momentum is negative (-0.95%/day)
- Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about ENL
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE Data Migration Contract with Penn Medicine
NONE Corporate Governance Statement & Appendix 4G
NONE Change of Director's Interest Notice
LOW Appendix 4E & 2025 Annual Report
Recent ASX Announcements
| 2026-03-22 | Data Migration Contract with Penn Medicine PRICE SENSITIVE |
| 2026-02-26 | Corporate Governance Statement & Appendix 4G |
| 2026-02-26 | Appendix 4E & 2025 Annual Report PRICE SENSITIVE |
| 2026-02-10 | Change of Director's Interest Notice |
| 2026-02-10 | Change of Director's Interest Notice |
Key Metrics
$5.8M
Market Cap
2.6M
Avg Volume
5.2x
Vol Ratio
$0.01 — $0.08
52-Week Range
0.1%
Short Interest
N/A
Cash Runway
-177.1%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 89% |
| L | Leader vs Laggard | laggard | RS: -14 |
| I | Institutional Sponsorship | weak | Inst: 8% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #102 of 117 · Sector avg: 46
View all Healthcare signals →Track ENL and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.
No credit card required